ASSOCIATE PROF. DR. POH MAU ERN
Department of Medicine
Faculty of Medicine
ernestpohum.edu.myView CV | |
View 1-Page CV | |
Publons | |
Biography | |
Professor Dr. Ernest Poh is Senior Consultant in respiratory medicine and Head of the Respiratory Division at Universiti Malaya. He is recipient of the Anugerah Staf Akademik Cemerlang Universiti Malaya (ACUM) 2025 and a recognized leader in bronchiectasis, lung cancer and COPD. Dr. Poh serves as faculty at international conferences and as principal investigator for clinical trials. He has secured over RM17.7 million in external grants and published extensively in high-impact journals, including Nature Medicine. Co-founder of the National Lung Cancer Registry, Dr Poh also formed the UM Lung Cancer Multidisciplinary Tumor Board back in 2018, positioning UM as a hub for thoracic oncology. As Deputy Chair of the Malaysian Thoracic Society’s Lung Cancer Special Interest Group, he drives national clinical guidelines and symposiums. In education, Dr. Poh mentors medical students and postgraduates, and serves as Clinical Coordinator for the undergraduate MBBS programme at Universiti Malaya. He is also a trainer and examiner for the Respiratory Subspecialty Examinations. He is an award-winning educator, receiving the Best Lecturer Award in 2018. His community contributions include media outreach, advisory roles with the NPRA, and peer review for Tier 1 journals, advancing UM’s academic and societal impact. |
Publication
Finance
Project Title | Progress | Status |
---|---|---|
Lignosus Rhinocerus Tm02? As An Immunomodulatory Agent For The Treatment Of Uncontrolled Asthma And Allergic Rhinitis: A Randomised, Double Blind, Placebo-control Study |
|
end |
This information is generated from Research Grant Management System |
Baseline predictors of mortality in non-idiopathic pulmonary fibrosis interstitial lung disease (Non-IPF ILD)
Does dose reduction of afatinib affect treatment outcomes of patients with <i>EGFR</i>-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Diagnostic yield, detection of driver alterations by next-generation sequencing and safety of EBUS-guided mediastinal cryobiopsy versus needle aspiration: A retrospective comparative study
Airway "Resistotypes" and Clinical Outcomes in Bronchiectasis